In a recent study, what proportion of breast cancer patients had coronary artery calcifications?
Are ctDNA levels prognostic of outcomes following neoadjuvant therapy and surgery for sarcoma?
What is the rate of acute skin adverse effects from proton versus photon breast/chest wall radiation?
Do clinicians and patients have good agreement in reporting adverse effects from prostate radiation?
Answers
29% had mild calcs and 28% had extensive calcs. In follow up, all patients who developed ischemic heart disease had extensive calcs on planning CT.
Yes, the personalized ctDNA panels used in this analysis of the SU2C-SARC032 trial identified ctDNA in 85% before treatment. Detectable ctDNA after treatment was associated with worse DFS and OS.
In the DBCG Proton Trial, protons had higher rates of acute grade 2–3 dermatitis (71% vs 20%), pruritus (20% vs 5%), and local pain (17% vs 4%).
No. In this analysis from HYPO-RT-PC, agreement was poor across multiple time points. | QuadShot News
Are ctDNA levels prognostic of outcomes following neoadjuvant therapy and surgery for sarcoma?
What is the rate of acute skin adverse effects from proton versus photon breast/chest wall radiation?
Do clinicians and patients have good agreement in reporting adverse effects from prostate radiation?
Answers
29% had mild calcs and 28% had extensive calcs. In follow up, all patients who developed ischemic heart disease had extensive calcs on planning CT.
Yes, the personalized ctDNA panels used in this analysis of the SU2C-SARC032 trial identified ctDNA in 85% before treatment. Detectable ctDNA after treatment was associated with worse DFS and OS.
In the DBCG Proton Trial, protons had higher rates of acute grade 2–3 dermatitis (71% vs 20%), pruritus (20% vs 5%), and local pain (17% vs 4%).
No. In this analysis from HYPO-RT-PC, agreement was poor across multiple time points. | QuadShot News